{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:00:27Z","timestamp":1769115627474,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To assess the risk for intraoperative and postoperative ocular bleeding associated with direct oral anticoagulant treatment in patients undergoing phacoemulsification surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Consecutive patients had phacoemulsification and intraocular lens implantation while taking uninterrupted direct oral anticoagulants (dabigatran, rivaroxaban, or apixaban). Gender and age-matched patients without antithrombotic therapy were used as the control group. Patients were examined one week postoperatively. Intraoperative and postoperative hemorrhagic and non-hemorrhagic complications were assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Forty patients (56 eyes) on direct oral anticoagulants and 120 patients (172 eyes) without anticoagulation, at a mean age of 77 years, had phacoemulsification. There was no significant difference between the groups in the rate of intraoperative and postoperative bleeding. One eye (1.8%) in the treatment group and 3 eyes (1.7%) in the control group had hyphema (<jats:italic>p<\/jats:italic>\u2009=\u20090.72). No patient had thromboembolic event during or after surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Cataract surgery was safely performed while continuing direct oral anticoagulation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10792-024-02944-x","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T06:02:05Z","timestamp":1708408925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of direct oral anticoagulants on bleeding during and after cataract surgery"],"prefix":"10.1007","volume":"44","author":[{"given":"Anat","family":"Maytal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadar","family":"Naidorf Rosenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reut","family":"Rotem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fani","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"2944_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jcrs.2015.12.002","volume":"42","author":"RA Blum","year":"2016","unstructured":"Blum RA, Lindfield D (2016) Direct oral anticoagulant drugs (DOAC). J Cataract Refract Surg 42:171\u2013172","journal-title":"J Cataract Refract Surg"},{"key":"2944_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jcjo.2013.11.007","volume":"49","author":"E Ing","year":"2014","unstructured":"Ing E, Douketis J (2014) New oral anticoagulants and oculoplastic surgery. Can J Ophthalmol 49:123\u2013127","journal-title":"Can J Ophthalmol"},{"key":"2944_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1160\/TH12-11-0868","volume":"110","author":"R Ferrandis","year":"2013","unstructured":"Ferrandis R, Castillo J, de Andr\u00e9s J, Gomar C, G\u00f3mez-Luque A, Hidalgo F et al (2013) The perioperative management of new direct oral anticoagulants: a question without answers. Thromb Haemost 110:515\u2013522","journal-title":"Thromb Haemost"},{"key":"2944_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1502000","volume":"373","author":"CV Pollack Jr","year":"2015","unstructured":"Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA et al (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373:511\u2013520","journal-title":"N Engl J Med"},{"key":"2944_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1182\/blood-2014-03-563056","volume":"124","author":"CH Yeh","year":"2014","unstructured":"Yeh CH, Gross PL, Weitz JI (2014) Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood 124:1020\u20131028","journal-title":"Blood"},{"key":"2944_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"2944_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"2944_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"2944_CR9","doi-asserted-by":"publisher","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH et al (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e326S-e350S","journal-title":"Chest"},{"key":"2944_CR10","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/S0161-6420(03)00785-1","volume":"110","author":"J Katz","year":"2003","unstructured":"Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG et al (2003) Study of medical testing for cataract surgery team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 110:1784\u20131788","journal-title":"Ophthalmology"},{"key":"2944_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/sj.eye.6703069","volume":"23","author":"JD Benzimra","year":"2009","unstructured":"Benzimra JD, Johnston RL, Jaycock P, Galloway PH, Lambert G, Chung AK et al (2009) The cataract national dataset electronic multicentre audit of 55567 operations: antiplatelet and anticoagulant medications. Eye 23:10\u201316","journal-title":"Eye"},{"key":"2944_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0886-3350(98)80133-8","volume":"24","author":"A Eriksson","year":"1998","unstructured":"Eriksson A, Koranyi G, Seregard S, Philipson B (1998) Risk of acute suprachoroidal hemorrhage with phacoemulsification. J Cataract Refract Surg 24:793\u2013800","journal-title":"J Cataract Refract Surg"},{"key":"2944_CR13","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0886-3350(00)00887-7","volume":"27","author":"Y Rotenstreich","year":"2001","unstructured":"Rotenstreich Y, Rubowitz A, Segev F, Jaeger-Roshu S, Assia EI (2001) Effect of warfarin therapy on bleeding during cataract surgery. J Cataract Refract Surg 27:1344\u20131346","journal-title":"J Cataract Refract Surg"},{"key":"2944_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jcrs.2010.01.017","volume":"36","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H (2010) Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 36:1115\u20131119","journal-title":"J Cataract Refract Surg"},{"key":"2944_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jcrs.2006.02.035","volume":"32","author":"N Kumar","year":"2006","unstructured":"Kumar N, Jivan S, Thomas P, McLure H (2006) Sub-Tenon\u2019s anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 32:1022\u20131025","journal-title":"J Cataract Refract Surg"},{"key":"2944_CR16","unstructured":"Royal college of ophthalmologists. Cataract surgery guidelines. September 2010. London, UK, scientific department, the royal college of ophthalmologists, 2010."},{"key":"2944_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M (2006) Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 47:1236\u20131240","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2944_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaophthalmol.2017.2199","volume":"135","author":"MT Sun","year":"2017","unstructured":"Sun MT, Wood MK, Chan W, Selva D, Sanders P, Casson RJ et al (2017) Risk of intraocular bleeding with novel oral anticoagulants compared with warfarin: a systematic review and meta-analysis. Jama Ophthalmol 135:864\u2013870","journal-title":"Jama Ophthalmol"},{"key":"2944_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/jamaophthalmol.2017.5677","volume":"136","author":"KE Uyhazi","year":"2018","unstructured":"Uyhazi KE, Miano T, Pan W, VanderBeek BL (2018) Association of novel oral antithrombotics with the risk of intraocular bleeding. JAMA Ophthalmol 136:122\u2013130","journal-title":"JAMA Ophthalmol"},{"key":"2944_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","volume":"126","author":"JS Healey","year":"2012","unstructured":"Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S et al (2012) Periprocedural bleeding and thromboembolic events with dabigatran compared to warfarin: results from the RE-LY randomized trial. Circulation 126:343\u2013348","journal-title":"Circulation"},{"key":"2944_CR21","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41433-019-0527-7","volume":"33","author":"R Patel","year":"2019","unstructured":"Patel R, De Klerk T (2019) Novel oral anticoagulants in cataract surgery - moving towards a national consensus regarding perioperative continuation. Eye 33:1820\u20131820","journal-title":"Eye"},{"key":"2944_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10792-018-0862-x","volume":"39","author":"J Cheung","year":"2018","unstructured":"Cheung J, Liu S, Li K (2018) Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications. Int Ophthalmol 39:623\u2013630","journal-title":"Int Ophthalmol"},{"key":"2944_CR23","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) ESC Scientific Document Group 2016. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893\u20132962","journal-title":"Eur Heart J"},{"key":"2944_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","volume":"379","author":"AS Levey","year":"2012","unstructured":"Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379:165\u2013180","journal-title":"Lancet"},{"key":"2944_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.juro.2009.04.025","volume":"182","author":"V Kupelian","year":"2009","unstructured":"Kupelian V, McVary KT, Kaplan SA, Hall SA, Link CL, Aiyer LP et al (2009) Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol 182:616\u2013624","journal-title":"J Urol"},{"key":"2944_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jcrs.2005.02.027","volume":"31","author":"DF Chang","year":"2005","unstructured":"Chang DF, Campbell JR (2005) Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 31:664\u2013673","journal-title":"J Cataract Refract Surg"},{"key":"2944_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/112067210501500209","volume":"15","author":"MC Desco","year":"2005","unstructured":"Desco MC, Navea A, Ferrer E, Menezo JL (2005) Effect of prophylactic brimonidine on bleeding complications after cataract surgery. Eur J Ophthalmol 15:228\u2013232","journal-title":"Eur J Ophthalmol"},{"key":"2944_CR28","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1177\/11206721221080621","volume":"32","author":"F Ucar","year":"2022","unstructured":"Ucar F, Yener HI (2022) Can bleeding in trabeculectomy be decreased? Effectiveness of brimonidine pre-treatment. Eur J Ophthalmol 32:3476\u20133481","journal-title":"Eur J Ophthalmol"},{"key":"2944_CR29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","volume":"69","author":"JU Doherty","year":"2017","unstructured":"Doherty JU, Gluckman TJ, Hucker WJ, Januzzi JL, Ortel TL, Saxonhouse SJ et al (2017) 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American college of cardiology clinical expert consensus document task force. J Am Coll Cardiol 69:871\u2013898","journal-title":"J Am Coll Cardiol"},{"key":"2944_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/europace\/eut083","volume":"15","author":"H Heidbuchel","year":"2013","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J et al (2013) European\u00a0Heart Rhythm\u00a0Association. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15:625\u2013651","journal-title":"Europace"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-02944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-02944-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-02944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:22:08Z","timestamp":1741879328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-02944-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2944"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-02944-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical approval was waived by the local Ethics Committee of Meir Medical Center in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was not required due to the retrospective nature of the data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"100"}}